Resources

• Lysosomal Proteomics for Lysosomal Storage Disorders

An application guide to using lysosomal proteomics for lysosomal storage disorders, covering enzymes, transporters, pathway remodeling, and project design.

• Lysosomal Proteomics in Neurodegenerative Disease Research

An application guide to lysosomal proteomics in neurodegenerative disease research, including Alzheimer-related study design, enrichment planning, and interpretation limits.

• Lysosomal Proteomics vs Whole-Cell Proteomics

A decision guide comparing lysosomal proteomics and whole-cell proteomics to help choose organelle enrichment or bulk cellular analysis for the study claim.

• Why Are Low-Abundance Lysosomal Proteins Hard to Detect?

A problem-solving guide explaining why low-abundance lysosomal proteins are hard to detect in bulk samples and how lysosome enrichment proteomics can improve detection chance without guaranteeing recovery.

• Lysosome Isolation for Proteomics: When Is Enrichment Needed?

A selection guide explaining when lysosome isolation and proteomics or lysosome enrichment proteomics is needed, and how to choose between laboratory isolation and customer-enriched fractions.

• What Is Lysosomal Proteomics Analysis and When Is It Useful?

A technical awareness guide to lysosomal proteomics analysis covering what the method measures, when it is useful, and how it differs from bulk proteomics.

• Integrated EV Isolation-to-Proteomics Service for Source Material-Based Exosome Studies

MtoZ Biolabs evaluates plasma, serum, urine, CSF, and cell culture-conditioned medium projects and supports EV isolation, enrichment or purification, applicable EV characterization, LC-MS/MS protein identification or quantitative proteomics, and corresponding data analysis according to the approved project scope.

• What Information Is Required to Evaluate a Metabolomics or Lipidomics Project?

MtoZ Biolabs evaluates metabolite- and lipid-focused projects using the research objective, sample matrix and condition, group structure, preparation history, target information, and expected quantification or annotation outcome.

• Exosome Proteomics Analysis Service for EV Protein Profiling and Comparative Research

MtoZ Biolabs supports project evaluation from source samples, pre-isolated EVs, EV protein lysates, or prepared peptides for LC-MS/MS protein identification, quantitative profiling, differential analysis, and project-specific candidate prioritization.

• Untargeted Metabolomics and Lipidomics Services: From Broad Profiling to Candidate Annotation

MtoZ Biolabs evaluates untargeted metabolomics and untargeted lipidomics projects based on the research objective, sample matrix, group design, preparation history, and expected result, with candidate annotation interpreted according to the available database and spectral evidence.